Annexon biosciences to participate in the 22nd annual needham virtual healthcare conference

Brisbane, calif., april 11, 2023 (globe newswire) -- annexon, inc. (nasdaq: annx) a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced that douglas love, president and chief executive officer, will participate in a fireside chat during the 22nd annual needham virtual healthcare conference on tuesday, april 18, 2023 at 1:30 p.m. et.
ANNX Ratings Summary
ANNX Quant Ranking